Once‐daily ICS/LABA combined inhalers vs once‐daily LAMA
Pneumonia · patients with chronic obstructive pulmonary disease
It is very uncertain whether once‐daily ICS/LABA combined inhalers changes pneumonia compared with once‐daily LAMA (very low certainty).
1 finding from 1 review
- Once‐daily long‐acting beta₂‐agonists/inhaled corticosteroids combined inhalers versus inhaled long‐acting muscarinic… 2018 · Cochrane Headline outcomes onlyOR 6.12 [0.73, 51.24]2 studies · 880 participantsVery low